Gemspring Capital’s portfolio company Zavation Medical Products has acquired US-based spinal implants provider CoreLink from the Stephens Group.

The Stephens Group will own a minority interest in the combined entity.

Zavation and CoreLink will continue to conduct operations under their respective brands.

Zavation CEO Jeffrey Johnson will lead the combined business, while CoreLink CEO Jay Bartling will serve as chairman of the board of directors.

Johnson said: “The combination of Zavation and CoreLink brings together two industry-leading businesses with shared values and customer-centric cultures.

“We remain dedicated to working with our distributor partners to deliver the highest quality spinal solutions for surgeons and patients across the country.”

The combined company will be able to continue investing in new technologies and offer improved customer service to surgeons and distributor partners.

CoreLink offers new devices and instrumentation for spinal surgery along with a differentiated product portfolio that supports lateral spine procedures.

The company internally designs and manufactures over 99% of its spinal implant systems. It uses in-house additive manufacturing techniques to develop Mimetic Metal technology, which enables enhanced patient outcomes.

CoreLink also developed a modern Bioskills facility in St. Louis, Missouri, to meet growing surgical requirements.

Gemspring managing director Don Gerne said: “Through this transformative combination, Zavation and CoreLink will be able to provide an expanded product suite and enhanced capabilities to remain hyper-responsive to the needs of customers and partners across the country.”

The companies have not disclosed the terms of the deal.